ProKidney’s stock rockets on ‘intriguing’ news, but analyst doesn’t recommend buying
MarketWatcharrow_outwardProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes
Yahoo Financearrow_outwardProKidney’s CKD cell therapy scores win in one half of phase 2 trial, falls short on other
Fierce Biotecharrow_outwardProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference - Stock Titan
Stock Titanarrow_outwardProKidney (PROK) Stock: Penny Stock Explodes 660% on Game-Changing Trial Results - MoneyCheck
MoneyCheckarrow_outwardIndividual investors who hold 32% of ProKidney Corp. (NASDAQ:PROK) gained 560%, institutions profited as well - simplywall.st
Simplywall.starrow_outwardStock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz - MSN
MSNarrow_outwardStock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz - Nasdaq
Nasdaqarrow_outwardProKidney Stock Skyrockets On Positive Trial Data; Citi Sees 60% Chance Of Success - Stocktwits
Stocktwitsarrow_outwardProKidney Is Soaring On Trial Results. How Should You Play Penny Stock PROK Here? - Barchart.com
Barchart.comarrow_outwardProKidney Is Soaring on Trial Results. How Should You Play Penny Stock PROK Here? - inkl
Inklarrow_outwardProKidney (PROK) Stock Surges Over 500% in a Staggering Intraday Rally - Daily Chhattisgarh News
Daily Chhattisgarh Newsarrow_outward$PROK stock is up 323% today. Here's what we see in our data. - Quiver Quantitative
Quiver Quantitativearrow_outwardProKidney Corp.: Major Moves in the Market - StocksToTrade
StocksToTradearrow_outwardProKidney stock soars after positive Phase 2 trial results - Investing.com
Investing.comarrow_outwardProKidney’s New Move: A Stock Reshuffle? - timothysykes.com
Timothysykes.comarrow_outwardWhy Is Penny Stock ProKidney Trading Higher On Tuesday? - Benzinga
Benzingaarrow_outwardWhy Is ProKidney Stock (PROK) Up 60% Today? - TipRanks
TipRanksarrow_outwardProKidney stock gains on trial data for lead drug (PROK:NASDAQ) - Seeking Alpha
Seeking Alphaarrow_outwardProkidney reports statistically and clinically significant topline results for the phase 2 REGEN-007 trial - MarketScreener
MarketScreenerarrow_outwardProKidney (PROK) Receives Downgrade and Price Target Cut | PROK Stock News - GuruFocus
GuruFocusarrow_outwardProKidney Corp. (NASDAQ:PROK) Shares Bought by Barclays PLC - Defense World
Defense Worldarrow_outwardsymbol__ Stock Quote Price and Forecast - CNN
CNNarrow_outwardIs Chamath Palihapitiya Giving Up on ProKidney (PROK) Stock? - InvestorPlace
InvestorPlacearrow_outwardWhy Shares of ProKidney Were Dropping Thursday - The Motley Fool
The Motley Foolarrow_outwardProKidney (PROK) Stock Price, News & Analysis - MarketBeat
MarketBeatarrow_outwardJohn M. Prok Obituary - Visitation & Funeral Information - Washburn-McReavy
Washburn-McReavyarrow_outward
Prok Stock close
- 2025-07-09 19:30 event
- 27 sourceslanguage
- 100+ ads_click
- 3 days ago schedule